| Patent | Date |
|---|
Double-stranded Nucleic Acid Complex And Use Thereof
App 20220307019 - YOKOTA; Takanori ; et al. | 2022-09-29 |
Blood-brain barrier permeable heteroduplex nucleic acid
Grant 11,433,089 - Yokota , et al. September 6, 2 | 2022-09-06 |
Pharmaceutical Composition for Treating Muscle Disease
App 20220175817 - YOKOTA; Takanori ; et al. | 2022-06-09 |
HETERO DOUBLE-STRANDED antimiR
App 20220154185 - Yokota; Takanori ; et al. | 2022-05-19 |
Optimal Ps Modification Pattern For Heteronucleic Acids
App 20220135972 - YOKOTA; Takanori ; et al. | 2022-05-05 |
Double-stranded nucleic acid complex having overhang
Grant 11,260,134 - Yokota , et al. March 1, 2 | 2022-03-01 |
.alpha.-synuclein expression inhibitor
Grant 11,234,995 - Nakamori , et al. February 1, 2 | 2022-02-01 |
Chimeric Double-stranded Nucleic Acid
App 20210340540 - Yokota; Takanori ; et al. | 2021-11-04 |
Inhibitor Of Tdp-43 Aggregation
App 20210317455 - YOKOTA; Takanori ; et al. | 2021-10-14 |
Bioelectric Current Estimation Method, Bioelectric Current Estimation Apparatus, Biomagnetic Measurement Apparatus, And Biomagnetic Measurement System
App 20210290143 - WATANABE; Taishi ; et al. | 2021-09-23 |
Chimeric double-stranded nucleic acid
Grant 11,034,955 - Yokota , et al. June 15, 2 | 2021-06-15 |
Double-stranded agents for delivering therapeutic oligonucleotides
Grant 11,028,387 - Yokota , et al. June 8, 2 | 2021-06-08 |
Bbb-passing Lipid Ligand Of Hetero Nucleic Acid
App 20210163934 - YOKOTA; Takanori ; et al. | 2021-06-03 |
Ischemic-lesion-site-specific Gene Therapy
App 20210130825 - YOKOTA; Takanori ; et al. | 2021-05-06 |
Carrier for use in delivering drug, conjugate, composition comprising same, and method for administrating same
Grant 10,912,838 - Kataoka , et al. February 9, 2 | 2021-02-09 |
Nucleic Acid Complex
App 20210024929 - Yokota; Takanori ; et al. | 2021-01-28 |
Nucleic Acid With Reduced Toxicity
App 20210010000 - YOKOTA; Takanori ; et al. | 2021-01-14 |
Chimeric single-stranded antisense polynucleotides and double-stranded antisense agent
Grant 10,844,374 - Yokota , et al. November 24, 2 | 2020-11-24 |
HETERO DOUBLE-STRANDED antimiR
App 20200115710 - Yokota; Takanori ; et al. | 2020-04-16 |
Chimeric Double-stranded Nucleic Acid
App 20190270996 - YOKOTA; TAKANORI ; et al. | 2019-09-05 |
Blood-brain Barrier Permeable Heteroduplex Nucleic Acid
App 20190247414 - Yokota; Takanori ; et al. | 2019-08-15 |
Double-stranded Nucleic Acid Complex Having Overhang
App 20190240352 - Yokota; Takanori ; et al. | 2019-08-08 |
Chimeric double-stranded nucleic acid
Grant 10,337,006 - Yokota , et al. | 2019-07-02 |
Chimeric double-stranded nucleic acid
Grant 10,329,567 - Yokota , et al. | 2019-06-25 |
Double-stranded antisense nucleic acid with exon-skipping effect
Grant 10,190,117 - Yokota , et al. Ja | 2019-01-29 |
a-SYNUCLEIN EXPRESSION INHIBITOR
App 20190008886 - NAKAMORI; Masayuki ; et al. | 2019-01-10 |
Chimeric Double-stranded Nucleic Acid
App 20180320181 - Yokota; Takanori ; et al. | 2018-11-08 |
Nucleic Acid Complex Having At Least One Bulge Structure
App 20180228830 - YANO; Junichi ; et al. | 2018-08-16 |
Nucleic Acid Complex
App 20180223280 - YANO; Junichi ; et al. | 2018-08-09 |
Carrier For Use In Delivering Drug, Conjugate, Composition Comprising Same, And Method For Administrating Same
App 20180185501 - Kataoka; Kazunori ; et al. | 2018-07-05 |
Carrier for use in delivering drug, conjugate, composition comprising same, and method for administrating same
Grant 9,937,263 - Kataoka , et al. April 10, 2 | 2018-04-10 |
Chimeric Double-stranded Nucleic Acid
App 20180073024 - YOKOTA; TAKANORI ; et al. | 2018-03-15 |
Chimeric double-stranded nucleic acid
Grant 9,816,089 - Yokota , et al. November 14, 2 | 2017-11-14 |
Chimeric Single-stranded Antisense Polynucleotides And Double-stranded Antisense Agent
App 20170275627 - Yokota; Takanori ; et al. | 2017-09-28 |
Pharmaceutical composition for transcolonic absorption
Grant 9,731,025 - Yokota , et al. August 15, 2 | 2017-08-15 |
Carrier For Use In Delivering Drug, Conjugate, Composition Comprising Same, And Method For Administrating Same
App 20160287714 - KATAOKA; Kazunori ; et al. | 2016-10-06 |
Double-stranded Agents For Delivering Therapeutic Oligonucleotides
App 20160145614 - YOKOTA; Takanori ; et al. | 2016-05-26 |
Double-stranded Antisense Nucleic Acid With Exon-skipping Effect
App 20160130583 - YOKOTA; Takanori ; et al. | 2016-05-12 |
Chimeric Single-stranded Antisense Polynucleotides And Double-stranded Antisense Agent
App 20160108395 - YOKOTA; Takanori ; et al. | 2016-04-21 |
Chimeric Double-stranded Nucleic Acid
App 20140302603 - Yokota; Takanori ; et al. | 2014-10-09 |
Pharmaceutical Composition For Transcolonic Absorption
App 20130210891 - Yokota; Takanori ; et al. | 2013-08-15 |
System for delivering nucleic acids for suppressing target gene expression by utilizing endogenous chylomicron
Grant 8,507,458 - Yokota , et al. August 13, 2 | 2013-08-13 |
System For Delivering Nucleic Acids For Suppressing Target Gene Expression By Utilizing Endogenous Chylomicron
App 20130116306 - Yokota; Takanori ; et al. | 2013-05-09 |
System for delivering nucleic acids for suppressing target gene expression by utilizing endogenous chylomicron
Grant 8,329,670 - Yokota , et al. December 11, 2 | 2012-12-11 |
System For Delivering Nucleic Acids For Suppressing Target Gene Expression By Utilizing Endogenous Chylomicron
App 20100234282 - YOKOTA; TAKANORI ; et al. | 2010-09-16 |
| 